Ir al contenido
LOGO-GRUPO-FARMA-ECUADOR-qkitlvkfv4z53nn67voev2cs3nycgtn8mt9lzsxfag
  • Home
  • About Us
    • History
    • The Company
    • Join the Team
    • Corporate governance
      • Committees
      • Human rights
      • Code of ethics
      • Speak Up – complaints channel
      • Risk management
      • Global policies
  • Our Products
    • Cardiovascular Line
    • Gastrointestinal Line
    • Gynecological Line
    • Iron Line
    • Supplements and Vitamins Line
    • Urological Line
    • Other Products
  • Patients
    • Pharmacovigilance
    • Products Guide
    • Frequent Questions
  • Healthcare Professionals
    • Product Guide
  • Contact Us
    • Grupo Farma
    • Venezuela
    • Colombia
    • Perú
  • ES
  • Home
  • About Us
    • History
    • The Company
    • Join the Team
    • Corporate governance
      • Committees
      • Human rights
      • Code of ethics
      • Speak Up – complaints channel
      • Risk management
      • Global policies
  • Our Products
    • Cardiovascular Line
    • Gastrointestinal Line
    • Gynecological Line
    • Iron Line
    • Supplements and Vitamins Line
    • Urological Line
    • Other Products
  • Patients
    • Pharmacovigilance
    • Products Guide
    • Frequent Questions
  • Healthcare Professionals
    • Product Guide
  • Contact Us
    • Grupo Farma
    • Venezuela
    • Colombia
    • Perú
  • ES
Grupo-Farma-del-Ecuador-Footer

GASTROINTESTINAL

Colypan® | GrupoFarma del Ecuador

GrupoFarma Ecuador Producto Gastrointestinal Colypan Plus 1 320x97 1-grupofarmadelecuador
BANNERS GFE Product COLYPAN BODEGON 1-grupofarmadelecuador

    Composition

  • Colypan: trimebutin.
  • Colypan Plus: trimebutin + simethicone.

    Presentation

  • Colypan 200mg x 30 coated tablets.
  • Colypan Plus 200 mg Trimebutin + 120 mg Simethicone x 30 tablets.
  • Colypan 300mg x 20 extended release tablets.
  • Colypan 50 mg/ 5ml IV Injectable Solution x 2 Ampoules (5 ml each containing 50 mg of trimebutin).

    Indications
    Colypan

  • Irritable Bowel Syndrome and associated discomfort such as abdominal pain.
  • Intestinal transit disorders in Irritable Bowel Syndrome (diarrhea/constipation/mixed).

    Colypan Plus

  • Irritable Bowel Syndrome and Dyspeptic Functional Disorders caused by Gas Retention and Abdominal Distension.

    Colypan injectable

  • Endoscopic procedures 1-2 ampoules prior to procedure (30 minutes before).
  • Postoperative Ileoparalytic and Emergency Pain Management: 1-2 ampoules per day.

    Sale under medical prescription.

Others Products

Imagen2-grupofarmadelecuador

Milpax®

Leer más
GrupoFarma Ecuador Producto Gastrointestinal Bioflora Plus 640x640 1-grupofarmadelecuador

Bioflora Plus®

Leer más
PACK Y ENVASE CULTIFLOR-grupofarmadelecuador

Cultiflor®

Leer más
pridot 1-grupofarmadelecuador

Pridot®

Leer más
GrupoFarma Ecuador Vonau Flash-grupofarmadelecuador

Vonau®

Leer más
GrupoFarma Ecuador Oralyte-grupofarmadelecuador

Oralyte®

Leer más
GrupoFarma Ecuador Producto Gastrointestinal Normix 2-grupofarmadelecuador

Normix®

Leer más
GrupoFarma Ecuador Producto Gastrointestinal Neolax 2-grupofarmadelecuador

Neolax®

Leer más
GrupoFarma Ecuador Producto Gastrointestinal Milpax NF 2 640x480 1-grupofarmadelecuador

Milpax NF®

Leer más
GrupoFarma Ecuador Producto Gastrointestinal HepaLive 3 640x480 1-grupofarmadelecuador

Hepalive®

Leer más
cropped-LOGO-GRUPO-FARMA-ECUADOR-qkitmzziop2enfzun2lxlu0is5zcbny4oxxaa7xa8g

Taking care of you very closely

Navigation

Home

News

Products

Frequent questions
 Work with us

Pharmacovigilance

Our Allies

Vidamine

Our Global Sites

Venezuela

Colombia

Peru

Grupo Farma

Contact

Edificio La Previsora, Torre A Oficina 902
Quito, Ecuador

(+593) 23819760

informacion.ecuador@gfe.com.ec

Lunes a Viernes
8:00 a.m a 5:00 p.m

The information provided on this website was prepared by  GrupoFarma del Ecuador. and directed exclusively to medical personnel and health professionals. It may NOT be considered general use for people, nor as medical advice, recommendations or medical advice of any kind. We suggest not to self-medicate and consult your doctor beforehand about any concerns related to the information on the products or drugs mentioned here.  GrupoFarma del Ecuador will not be responsible for the misuse that third parties may give to the information obtained here.

© All rights reserved. 2023. Grupo Farma S.A. RIF J-00013393-0. Ecuador

Youtube Linkedin Facebook Instagram

Are you a
Health Professional?

Yes
No